Livrables
Data management and validation plan final To facilitate the obligation to make research data available within 30 days following guidelines for H2020 projects working on COVID19 available at httpseuYh49yCProtection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
Data management and validation plan M12Data management and validation plan M12 To facilitate the obligation to make research data available within 30 days following guidelines for H2020 projects working on COVID19 available at httpseuYh49yCProtection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
Data management and validation planDMPs should cover strategy for all data in the project and how they can be made available as from the rules 30days Protection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
'IV imatinib in severe Covid-19' study peer reviewed publicationIV imatinib in severe Covid19 study peer reviewed publication submitted for review
'Oral imatinib in severe Covid-19' study peer reviewed publicationPeer reviewed publication reporting findings from the oral Phase II clinical study
Presentation of 'IV imatinib in severe Covid-19' study result at ERS, ESICM and ATS congressesPreparation of an abstract for presentation of IV imatinib in severe Covid19 study result at an international conference eg ATS
Pathophysiology report & manuscriptreport and manuscript for publication describing pathophysiology findings from the oral phase II clinical study
Public presentations of findings from the oral Phase II clinical study
Publications
Auteurs:
J. De Brabander 1, E. Duijvelaar 4, J.R. Schippers 4, P.J. Smeele 4, J. Duitman 3, J. Aman 4, H.J. Bogaard 4, T. van der Poll 1, L.D.J. Bos 2, CounterCOVID Study Group
Publié dans:
American Thoracic Society International Conference Abstracts, 2022
Éditeur:
American Thoracic Society
DOI:
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5049
Auteurs:
J. Schippers, E. Duijvelaar, P. Smeele, M. De Raaf, S. Blok, A. Vanhove, F. De Man, H. J. Bogaard, J. Aman
Publié dans:
American Thoracic Society International Conference Abstracts, 2022
Éditeur:
American Thoracic Society
DOI:
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5048
Auteurs:
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job Schippers, Patrick Smeele, Sara Azhang, Imke Bartelink, Pierre Bet, Wim Boersma, Karin Boomars, Peter Bonta, Lieuwe Bos, Job Van Bragt, Gert-Jan Braunstahl, Lucas Celant, Katrien Eger, Miranda Geelhoed, Yurika Van Glabbeek, Hans GrotjohanShow lessLaura Hagens, Chris Happe, Leo Heunks, Michel Van Den Heuvel, Wouter Hoefsloot, Rianne Hoek,
Publié dans:
European Respiratory Journal, 2021
Éditeur:
European Respiratory Society
DOI:
10.1183/13993003.congress-2021.oa4119
Auteurs:
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele, Sara Azhang, Imke H Bartelink, Ahmed A Bayoumy, Pierre M Bet, Wim Boersma, Peter I Bonta, Karin A T Boomars, Lieuwe D J Bos, Job J M H van Bragt, Gert-Jan Braunstahl, Lucas R Celant, Katrien A B Eger, J J Miranda Geelhoed, Yurika L E van Glabbeek, Hans P Grotjohan, Laura A Hagens, Chris M Happe, Boaz D Haze
Publié dans:
The Lancet Respiratory Medicine, Numéro 9/9, 2021, Page(s) 957-968, ISSN 2213-2600
Éditeur:
Elsevier Limited
DOI:
10.1016/s2213-2600(21)00237-x
Auteurs:
Erik Duijvelaar; Job R Schippers; Patrick J Smeele; Michiel Alexander de Raaf; Arthur L E M Vanhove; Siebe G Blok; CounterCOVID Collaborative Group; Jos W R Twisk; Anton Vonk Noordegraaf; Frances S de Man; Harm Jan Bogaard; Jurjan Aman
Publié dans:
The Lancet Respiratory Medicine, Numéro 22132600, 2022, ISSN 2213-2600
Éditeur:
Elsevier Limited
DOI:
10.1016/s2213-2600(22)00052-2
Auteurs:
Leila Atmowihardjo, Job R. Schippers, Imke H. Bartelink, Pierre M. Bet, Nienke van Rein, Keith Purdy, David Cavalla, Valérie Comberiati, Andrew McElroy, Sue D. Snape, Harm Jan Bogaard, Leo Heunks, Nicole Juffermans, Marcus Schultz, Pieter R. Tuinman, Lieuwe D. J. Bos & Jurjan Aman
Publié dans:
Trials, Numéro 17456215, 2022, ISSN 1745-6215
Éditeur:
BioMed Central
DOI:
10.1186/s13063-022-06055-9
Auteurs:
Justin de Brabander, Erik Duijvelaar, Job R. Schippers, Patrick J. Smeele, Hessel Peters-Sengers, Jan Willem Duitman, Jurjan Aman, Harm J. Bogaard, Tom van der Poll, Lieuwe D.J. Bos on behalf of the CounterCOVID study group
Publié dans:
European Respiratory Journal, Numéro 13993003, 2022, ISSN 1399-3003
Éditeur:
European Respiratory Society
DOI:
10.1183/13993003.00780-2022
Auteurs:
Imke H. Bartelink, Pierre M. Bet, Nicolas Widmer, Monia Guidi, Erik Duijvelaar, Bram Grob, Richard Honeywell, Amanda Evelo, Ivo P. E. Tielbeek, Sue D. Snape, Henrike Hamer, Laurent A. Decosterd, Harm Jan Bogaard, Jurjan Aman, Eleonora L. Swart
Publié dans:
CPT: Pharmacometrics & Systems Pharmacology, Numéro 5 October 2021, 2021, ISSN 2163-8306
Éditeur:
Nature Publishing Group
DOI:
10.1002/psp4.12718
Recherche de données OpenAIRE...
Une erreur s’est produite lors de la recherche de données OpenAIRE
Aucun résultat disponible